Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Amiodarone and Simvastatin Legal News Articles & Interviews

FDA Announces Safety Changes for Simvastatin

FDA Announces Safety Changes for Simvastatin June 8, 2011. By Heidi Turner.
Washington, DC The US Food and Drug Administration (FDA) has announced a change in the safety label for simvastatin (sold under the brand-name Zocor) because high-dose simvastatin has been linked to an increased risk of myopathy. The FDA recommends that 80 mg simvastatin, the highest dose approved by the FDA, only be used in patients who have already taken the dose for 12 months or more and have not developed muscle toxicity. Furthermore, the 80 mg simvastatin dose should not be prescribed to new patients.
Read [ FDA Announces Safety Changes for Simvastatin ]

Scientists Discover Previously Unknown Simvastatin Effect

Scientists Discover Previously Unknown Simvastatin Effect February 21, 2011. By Charles Benson.
Utica, NY Scientists at the Masonic Medical Research Laboratory in Utica, New York, recently discovered a potential benefit of simvastatin in suppressing the occurrence of some forms of abnormal heart rhythms, reports WKTV, a local NBC affiliate.
Read [ Scientists Discover Previously Unknown Simvastatin Effect ]

Amiodarone or Multaq: Where Should Patients Turn?

Amiodarone or Multaq: Where Should Patients Turn? February 11, 2011. By Heidi Turner.
Portland, OR When it comes to taking amiodarone, much of the concern is about amiodarone and simvastatin interaction. Although it is true that the combination of amiodarone and simvastatin can cause complications, amiodarone by itself has reportedly been linked to an increased risk of pulmonary toxicity, which could potentially be deadly.
Read [ Amiodarone or Multaq: Where Should Patients Turn? ]

French Company to Warn US Doctors of Side Effects of Drug Similar to Amiodarone

French Company to Warn US Doctors of Side Effects of Drug Similar to Amiodarone January 22, 2011. By Charles Benson.
Paris, France France's largest drugmaker, Sanofi-Aventis SA, is expected to send a letter to US doctors to inform them of two cases of liver failure in patients taking a drug similar to amiodarone, Bloomberg reports.
Read [ French Company to Warn US Doctors of Side Effects of Drug Similar to Amiodarone ]

Amiodarone: When Off-Label Drug Use Hurts Patients

Amiodarone: When Off-Label Drug Use Hurts Patients January 9, 2011. By Heidi Turner.
Washington, DC When it comes to medications such as amiodarone, what the patient does not know can definitely hurt him. Problems with amiodarone, such as amiodarone side effects and amiodarone interactions with other drugs, have reportedly put patient's lives at risk. The worst part might be that many of them were prescribed the medication for off-label use.
Read [ Amiodarone: When Off-Label Drug Use Hurts Patients ]

Amiodarone: Father Went into Hospital and Never Came Out

Amiodarone: Father Went into Hospital and Never Came Out January 4, 2011. By Heidi Turner.
Houston, TX When Robert R. was put on amiodarone, his family thought the drug was necessary to treat his condition. They did not realize that, because of amiodarone side effects, the US Food and Drug Administration (FDA) had only approved amiodarone as a drug of last resort. Furthermore, they did not realize that the drug could result in amiodarone lung toxicity and was only approved for patients with life-threatening ventricular arrhythmia, which Robert did not have.
Read [ Amiodarone: Father Went into Hospital and Never Came Out ]

Amiodarone Interaction with Simvastatin Still a Global Concern

Amiodarone Interaction with Simvastatin Still a Global Concern December 20, 2010. By Gordon Gibb.
Shanghai, China The Republic of China has now caught on to the pre-existing concern over simvastatin when combined with amiodarone, given a release in November by the State Food and Drug Administration (SFDA) in China warning about the risk of rhabdomyolysis, a rare muscle injury that can lead to kidney failure and death. Simvastatin taken alone in high doses, or taken together with amiodarone, can cause grievous health issues.
Read [ Amiodarone Interaction with Simvastatin Still a Global Concern ]

Amiodarone and Simvastatin Anything But a Dynamic Duo

Amiodarone and Simvastatin Anything But a Dynamic Duo November 19, 2009. By Gordon Gibb.
Kansas City, MO The relationship between simvastatin and amiodarone, together with the amiodarone interaction identified as simvastatin rhabdomyolysis, came to the forefront in August of last year when the FDA issued an alert to health care professionals regarding the risk for rhabdomyolysis when simvastatin is used in association with amiodarone.
Read [ Amiodarone and Simvastatin Anything But a Dynamic Duo ]

Off-label use of Amiodarone may be dangerous

Off-label use of Amiodarone may be dangerous November 4, 2009. By Charles Benson.
Silver Spring, MD According to the FDA, one in five U.S. doctors who write prescriptions from common use drugs do so for off-label use, which is what has allegedly occurred with the irregular heartbeat medication Amiodarone.
Read [ Off-label use of Amiodarone may be dangerous ]

Amiodarone + Simvastatin = Increased Risk: FDA

Amiodarone + Simvastatin = Increased Risk: FDA October 18, 2009. By Gordon Gibb.
Washington, DC An adverse reaction to statin use, including amiodarone interaction and simvastatin side effect, was identified by the US Food and Drug Administration (FDA) last year. And while simvastatin rhabdomyolysis is rare, researchers from the University of Western Ontario warned that side effects are likely to increase as more patients were prescribed amiodarone, and as LDL cholesterol targets tightened.
Read [ Amiodarone + Simvastatin = Increased Risk: FDA ]


Request Legal Help Now! - Free